State of the (HE)ART: CVD risk prediction and management
Munich Diabetes Research Group + D&CVD EASD Study Group

World Diabetes Congress, Dubai, United Arab Emirates, 06-Dec-11

Holman, Prof. R., Oxford, United Kingdom
Estimating individual CVD risk in Type 2 diabetes
Schnell, Prof. O., Munich, Germany
Self-monitoring of blood glucose: Impact on CV risk in diabetes
Hanefeld, Prof. M., Dresden, Germany
Patterns of continuous glucose monitoring: A role for prediction or cardiac arrhythmias?
Standl, Prof. E., Munich, Germany
Statin and RAAS inhibitor for every diabetic patient?
Ji, Prof. L., Peking, China
Diabetes in Asia: Strategies for CVD prevention
Ceriello, Prof. A., Barcelona, Spain
The need for individualized medicine in diabetes